We describe a 14-month-old male patient diagnosed with XL-CGD (mutation CYBB c.175 T>C), who was successfully transplanted with peripheral blood stem cells (PBMC) from his HLA-haploidentical father.

Chimeric antigen receptor (CAR) T-cell therapy offers an effective therapeutic option for patients with lymphoid malignancies (1–3). CD19 antigen was commonly selected in CAR-T treatment of B cell ...